A citation-based method for searching scientific literature

Jin Kyung Seok, Han Chang Kang, Yong-Yeon Cho, Hye Suk Lee, Joo Young Lee. Front Immunol 2021
Times Cited: 13







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Mechanism and Regulation of NLRP3 Inflammasome Activation.
Yuan He, Hideki Hara, Gabriel Núñez. Trends Biochem Sci 2016
23

K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo, Peter Kuffa, Giovanny Martínez-Colón, Brenna L Smith, Thekkelnaycke M Rajendiran, Gabriel Núñez. Immunity 2013
23

Inflammasomes: mechanism of action, role in disease, and therapeutics.
Haitao Guo, Justin B Callaway, Jenny P-Y Ting. Nat Med 2015
23

NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
Yuan He, Melody Y Zeng, Dahai Yang, Benny Motro, Gabriel Núñez. Nature 2016
510
23

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.
Nathan Kelley, Devon Jeltema, Yanhui Duan, Yuan He. Int J Mol Sci 2019
639
23

Mechanisms and functions of inflammasomes.
Mohamed Lamkanfi, Vishva M Dixit. Cell 2014
23

Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.
Teresa Fernandes-Alnemri, Seokwon Kang, Connor Anderson, Junji Sagara, Katherine A Fitzgerald, Emad S Alnemri. J Immunol 2013
149
23

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.
Yang Yang, Huanan Wang, Mohammed Kouadir, Houhui Song, Fushan Shi. Cell Death Dis 2019
430
23

The NLRP3 inflammasome: molecular activation and regulation to therapeutics.
Karen V Swanson, Meng Deng, Jenny P-Y Ting. Nat Rev Immunol 2019
23

IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation.
Keng-Mean Lin, Wei Hu, Ty Dale Troutman, Michelle Jennings, Travis Brewer, Xiaoxia Li, Sambit Nanda, Philip Cohen, James A Thomas, Chandrashekhar Pasare. Proc Natl Acad Sci U S A 2014
155
23

NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway.
Iva Hafner-Bratkovič, Petra Sušjan, Duško Lainšček, Ana Tapia-Abellán, Kosta Cerović, Lucija Kadunc, Diego Angosto-Bazarra, Pablo Pelegrin, Roman Jerala. Nat Commun 2018
52
15

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro.
Anna Gritsenko, Shi Yu, Fatima Martin-Sanchez, Ines Diaz-Del-Olmo, Eva-Maria Nichols, Daniel M Davis, David Brough, Gloria Lopez-Castejon. Front Immunol 2020
24
15

Inhibiting the NLRP3 Inflammasome.
Lina Y El-Sharkawy, David Brough, Sally Freeman. Molecules 2020
21
15

Targeting the NLRP3 inflammasome in inflammatory diseases.
Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick, Eicke Latz. Nat Rev Drug Discov 2018
486
15

Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.
Humayun Sharif, Li Wang, Wei Li Wang, Venkat Giri Magupalli, Liudmila Andreeva, Qi Qiao, Arthur V Hauenstein, Zhaolong Wu, Gabriel Núñez, Youdong Mao,[...]. Nature 2019
200
15

Activation and regulation of the inflammasomes.
Eicke Latz, T Sam Xiao, Andrea Stutz. Nat Rev Immunol 2013
15

Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming.
Jack P Green, Shi Yu, Fátima Martín-Sánchez, Pablo Pelegrin, Gloria Lopez-Castejon, Catherine B Lawrence, David Brough. Proc Natl Acad Sci U S A 2018
63
15

MCC950 closes the active conformation of NLRP3 to an inactive state.
Ana Tapia-Abellán, Diego Angosto-Bazarra, Helios Martínez-Banaclocha, Carlos de Torre-Minguela, Jose P Cerón-Carrasco, Horacio Pérez-Sánchez, Juan I Arostegui, Pablo Pelegrin. Nat Chem Biol 2019
129
15

An update on the regulatory mechanisms of NLRP3 inflammasome activation.
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, Chihiro Sasakawa, Eun-Kyeong Jo. Cell Mol Immunol 2021
50
15

NLRP3 inflammasome and its inhibitors: a review.
Bo-Zong Shao, Zhe-Qi Xu, Bin-Ze Han, Ding-Feng Su, Chong Liu. Front Pharmacol 2015
379
15

NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
Amna Abderrazak, Tatiana Syrovets, Dominique Couchie, Khadija El Hadri, Bertrand Friguet, Thomas Simmet, Mustapha Rouis. Redox Biol 2015
400
15

Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/caspase-1/GSDMD Pathway in MPTP Induced Mice Model of Parkinson's Disease.
Wenjuan Rui, Sheng Li, Hong Xiao, Ming Xiao, Jingping Shi. Int J Neuropsychopharmacol 2020
24
15


Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
Stefani Spranger, Riyue Bao, Thomas F Gajewski. Nature 2015
15

The inflammasome NLRs in immunity, inflammation, and associated diseases.
Beckley K Davis, Haitao Wen, Jenny P-Y Ting. Annu Rev Immunol 2011
15

NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.
Jun Yin, Fanpeng Zhao, Jeremy E Chojnacki, Jacob Fulp, William L Klein, Shijun Zhang, Xiongwei Zhu. Mol Neurobiol 2018
93
15

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
Andrea Stutz, Carl-Christian Kolbe, Rainer Stahl, Gabor L Horvath, Bernardo S Franklin, Olivia van Ray, Rebecca Brinkschulte, Matthias Geyer, Felix Meissner, Eicke Latz. J Exp Med 2017
161
15

Inflammasomes: mechanism of assembly, regulation and signalling.
Petr Broz, Vishva M Dixit. Nat Rev Immunol 2016
15

Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.
Christine Juliana, Teresa Fernandes-Alnemri, Seokwon Kang, Andrew Farias, Fengsong Qin, Emad S Alnemri. J Biol Chem 2012
441
15

Antitumour glycopeptides from Lactobacillus bulgaricus cell wall.
I G Bogdanov, P G Dalev, A I Gurevich, M N Kolosov, V P Malékova, L A Plemyannikova, I B Sorokina. FEBS Lett 1975
58
7

GMDP for psoriasis.
D Williamson, M Chawla, R Marks. Lancet 1998
5
20

The Role of the p38-MNK-eIF4E Signaling Axis in TNF Production Downstream of the NOD1 Receptor.
Mikhail V Pashenkov, Lyudmila S Balyasova, Yulia A Dagil, Boris V Pinegin. J Immunol 2017
13
7

Modulation of muramyl dipeptide stimulation of cytokine production by blood components.
J H M van der Meer, M G Netea, C A Dinarello. Clin Exp Immunol 2009
16
7

[Restorative effect of muroctasin; MDP-Lys (L18) [DJ-7041] on leukopenia in urogenital cancer patients treated with chemotherapy].
K Oishi, H Takeuchi, O Yoshida, K Nakagawa, T Fukuyama, K Okamoto, Y Kihara, H Okuno, T Shirahase, T Tomoyoshi. Hinyokika Kiyo 1989
1
100

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.
S Zolla-Pazner, C Alving, R Belshe, P Berman, S Burda, P Chigurupati, M L Clements, A M Duliege, J L Excler, C Hioe,[...]. J Infect Dis 1997
48
7

Sleep-promoting effects of muramyl peptides.
J M Krueger, J R Pappenheimer, M L Karnovsky. Proc Natl Acad Sci U S A 1982
191
7

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants.
R Bomford, M Stapleton, S Winsor, A McKnight, T Andronova. AIDS Res Hum Retroviruses 1992
83
7



Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.
Kevin Chu Foy, Ruthie M Wygle, Megan J Miller, Jay P Overholser, Tanios Bekaii-Saab, Pravin T P Kaumaya. J Immunol 2013
28
7

[Domestic immunomodulator of a new generation, Licopid, in the comprehensive therapy and prevention of infectious complications in surgery].
L I Vinnitskiĭ, K A Buniatian, B V Pinegin, E V Mironova, L I Shvets, A A Volkov, E V Inviiaeva, T M Andronova, R M Khaitov. Vestn Ross Akad Med Nauk 1997
1
100

Therapeutic targeting of trained immunity.
Willem J M Mulder, Jordi Ochando, Leo A B Joosten, Zahi A Fayad, Mihai G Netea. Nat Rev Drug Discov 2019
139
7





Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide.
Verónica Athié-Morales, Geraldine M O'Connor, Clair M Gardiner. J Immunol 2008
28
7

MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.
Qilin Pan, John Mathison, Colleen Fearns, Vladimir V Kravchenko, Jean Da Silva Correia, Hal M Hoffman, Koichi S Kobayashi, John Bertin, Ethan P Grant, Anthony J Coyle,[...]. J Leukoc Biol 2007
111
7

Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope method.
M Fukuoka, M Takada, N Takifuji, N Sakai, S Ryu, N Masuda, K Matsui, S Negoro, Y Kusunoki, E Tubura. Arzneimittelforschung 1989
9
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.